Correlates of human papillomavirus viral load with infection site in asymptomatic men

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3573-3576

  Flores, Roberto ^a   Beibei, Lu ^b   Nielson, Carrie ^c   Abrahamsen, Martha ^b   Wolf, Kyle ^b   Lee, Ji Hyun ^b   Harris, Robin B ^d   Giuliano, Anna R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DNA DETERMINATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD;

ADULT; CROSS-SECTIONAL STUDIES; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PENIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; VIRAL LOAD; VIRUS REPLICATION;

EID: 57449105088     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0467     Document Type: Article

References (24)

1. Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;2:1010-5.
2. Zunzunegui MV, King MC, Coria CF, Charlet J. Male influences on cervical cancer risk. Am J Epidemiol 1986;123:302-7.
3. Agarwal SS, Sehgal A, Sardana S, Kumar A, Luthra UK. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 1993;72:1666-9.
4. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection and cervical cancer in female partners. N Engl J Med 2002;346:1105-12.
5. Bleeker MC, Hogewoning CJ, Berkhof J, et al. Concordan ce of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005;41:612-20.
6. De Marco F, Di Carlo A, Poggiali F, Muller A, Marcante ML. Detection of HPV in genital condylomata: correlation between viral load and clinical outcome. J Exp Clin Cancer Res 2001;20:377-83.
7. Sanclemente G, Herrera S, Tyring SK, et al. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia. J Eur Acad Dermatol Venereol 2007;21:1054-60.
8. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
9. Hart KW, Williams OM, Thelwell N, et al. Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol 2001;39:3204-12.
10. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001;83:95-9.
11. Beskow AH, Gyllensten UB. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 2002;101:526-31.
12. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002;76:41-7.
13. Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2189-93.
14. Ylitalo N, Sorensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.
15. van Duin M, Snijders PJ, Schrijnemakers HF, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590-5.
16. Giuliano AR, Nielson CM, Flores R, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007;196:1146-52.
17. Nielson CM, Flores R, Harris RB, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007;16:1107-14.
18. Nielson CM, Harris RB, Dunne EF, et al. Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007;196:1137-45.
19. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
20. Kornegay JR, Shepard AP, Hankins C, et al. Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. J Clin Microbiol 2001;39:3530-6.
21. Flores-Munguia R, Siegel E, Klimecki W, Giuliano AR. Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J Mol Diagnos 2004;6:115-24.
22. Flores R, Papenfuss M, Klimecki WT, Giuliano AR. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 2006;118:1187-93.
23. Chambers A, Perry M. Salivary mediated autoinoculation of herpes simplex virus on the face in the absence of "cold sores," after trauma. J Oral Maxillofac Surg 2008;66:136-8.
24. Wolf R, Davidovici B, Marcus B, Orion E, Lipozencic J. Autoinoculation and dissemination are two different forms of herpes virus spread. Acta Dermatovenerol Croat 2006;14:258-60.